rxstat › Classes › Lipid Modifying Agents, Plain
Lipid Modifying Agents, Plain: shortage status in Canada
10 of the 16 lipid modifying agents, plain rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.
Partial shortageAtorvastatin11 of 64 reported products affected · est. return Jun 1, 2027Partial shortageCholestyramine Resin1 of 4 reported products affected · est. return Oct 3, 2027Partial shortageColestipol1 of 3 reported products affectedPartial shortageEzetimibe4 of 18 reported products affectedPartial shortageFluvastatin1 of 3 reported products affected · est. return Aug 31, 2026Partial shortageGemfibrozil1 of 3 reported products affectedPartial shortageLovastatin2 of 10 reported products affectedPartial shortagePravastatin12 of 49 reported products affected · est. return May 15, 2026Partial shortageRosuvastatin9 of 65 reported products affected · est. return Jun 30, 2026Partial shortageSimvastatin15 of 65 reported products affected · est. return Dec 25, 2026No current shortageAlirocumabNo current shortageBezafibrateNo current shortageColesevelamDiscontinuedEvolocumab0 of 1 reported products affectedNo current shortageFenofibrateDiscontinuedNicotinic Acid0 of 6 reported products affected
Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.